Colossal Biosciences Series C

Health Care · United States · $200M

Colossal Biosciences raised $200 million in a Series C round announced January 15, 2025, led by TWG Global (Mark Walter and Thomas Tull), with additional strategic investors including USIT, Animal Capital, Breyer Capital, At One Ventures, In-Q-Tel, BOLD Capital, Peak6, and Draper Associates, plus private investors Robert Nelsen, Peter Jackson, Fran Walsh, Ric Edelman, Brandon Fugal, Paul Tudor Jones, Richard Garriott, Giammaria Giuliani, Sven-Olof Lindblad, Victor Vescovo, and Jeff Wilke. The round valued Colossal at $10.2 billion and brought total funding to $435 million.